WHO Agency Reports One in Eight Global Cancer Cases Tied to Infections

A significant proportion of the world's cancer burden can be traced back to infectious agents, according to new findings from an agency affiliated with the World Health Organization. The research indicates that roughly one out of every eight cancer diagnoses globally is connected to an infection, a finding that underscores the potential for prevention strategies that go beyond lifestyle changes and early detection.

The figure, which represents approximately 12.5 percent of all cancer cases, highlights the role that viruses, bacteria, and parasites play in the development of malignancies. While many people associate cancer with genetic predisposition, environmental toxins, or behaviors such as smoking and poor diet, the contribution of chronic infections is often overlooked in public discourse.

The WHO agency's assessment suggests that a substantial number of these infection-related cancers could be prevented through existing public health measures. Vaccination programs, improved sanitation, and broader access to screening and treatment for infectious diseases are among the tools that could significantly reduce the incidence of these cancers.

Among the infectious agents most commonly linked to cancer are the human papillomavirus (HPV), which is associated with cervical and other cancers; hepatitis B and C viruses, which can lead to liver cancer; and the bacterium Helicobacter pylori, which is a major cause of stomach cancer. Each of these has been the subject of extensive research and, in some cases, the development of effective vaccines or treatments.

The human papillomavirus, for instance, is responsible for the vast majority of cervical cancer cases. The introduction of HPV vaccines has provided a powerful preventive tool, yet global vaccination coverage remains uneven. In many low- and middle-income countries, where the burden of cervical cancer is highest, access to the vaccine is still limited by cost, supply chain challenges, and gaps in healthcare infrastructure.

Similarly, chronic hepatitis B and C infections are leading causes of liver cancer worldwide. While a vaccine exists for hepatitis B, it is not universally available at birth, and hepatitis C, though now curable with antiviral medications, often goes undiagnosed in regions with weak health systems. The WHO has set targets for eliminating viral hepatitis as a public health threat, but progress has been mixed.

Helicobacter pylori, a bacterium that colonizes the stomach, is another major contributor. It is estimated that a significant share of stomach cancers can be attributed to this infection, which can be treated with a course of antibiotics. However, in many parts of the world, screening for H. pylori is not routine, and the infection often persists for decades before symptoms prompt medical attention.

The findings carry profound implications for global health policy. They suggest that investments in infectious disease control could yield substantial dividends in cancer prevention. This is particularly relevant for low- and middle-income countries, where infection-related cancers make up a larger proportion of the overall cancer burden compared to wealthier nations.

In high-income countries, where smoking cessation and cancer screening have reduced the incidence of certain cancers, the relative contribution of infections may be smaller. Yet the absolute number of cases remains significant, and disparities in access to preventive care persist even within affluent societies.

The WHO agency's report also points to the need for integrated health services. Rather than treating infectious disease control and cancer prevention as separate silos, there is a growing argument for combining efforts. For example, cervical cancer screening can be paired with HPV vaccination campaigns, and hepatitis testing can be integrated into routine healthcare visits.

Experts in global oncology have long argued that the fight against cancer cannot be won without addressing infections. The new data reinforces that position, providing a clear numerical basis for prioritizing infection-related cancer prevention. It also highlights the importance of surveillance systems that can track both infectious diseases and cancer outcomes, allowing health authorities to measure the impact of interventions over time.

The COVID-19 pandemic demonstrated how quickly infectious diseases can disrupt health systems and divert resources from other priorities. As the world continues to recover, there is an opportunity to rebuild health services in ways that strengthen both infectious disease control and cancer care. The WHO agency's findings offer a roadmap for such integration, emphasizing prevention as a cornerstone of sustainable health systems.

For individuals, the message is one of awareness and action. Vaccination against HPV and hepatitis B, regular screening for cervical and liver cancer, and timely treatment for bacterial infections like H. pylori can significantly reduce the risk of developing infection-related cancers. These steps are especially important for people living in regions where such infections are common.

Ultimately, the one-in-eight statistic is more than a number. It represents millions of preventable cancer cases and a clear call to action for governments, health organizations, and communities. By focusing on infections as a modifiable risk factor, the global health community has an opportunity to make meaningful progress in reducing the cancer burden and improving outcomes for people around the world.